Acute Leukemias Flashcards

(44 cards)

1
Q

ALL cases more frequently involve _____ cells (~80%).

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

__-ALL is more commonly seen in adolescents and young adults.

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

__-ALL is more commonly seen in children.

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

__-ALL is more commonly seen in men than women

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

__-ALL is more likely to present with a large mediastinal mass.

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

B-ALL has a ______ prognosis than T-ALL.

A

better

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

B-ALL is more commonly seen in _____ (demographic).

A

children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cytogenetic abnormalities associated with AML due to CBFB-MYH11

A

inv(16)(p13.1;q22) or t(16;16)(p13.1;q22)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cytogenetic abnormality associated with a poor prognosis AML

A

11q23 MLL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cytogenetic abnormality associated with AML due to RNX1-RNX1T1

A

t(8;22)(q22;q22)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cytogenetic abnormality associated with AML with megakaryoblastic differentiation

A

t(1;22)(p13;q13), RBM15-MKL1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cytogenetic abnormality associated with APML

A

t(15;17)(q22q22)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cytogenetic abnormality most often seen in infants with Down Syndrome

A

t(1;22)(p13;q13), RBM15-MKL1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cytogenetic finding associated with AML with monocytic differentiation

A

11q23 MLL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cytogenetic finding associated with B-ALL in neonates and young infants

A

11q23 MLL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cytogenetic finding associated with the worst prognosis of any ALL

A

T(9;22)(q34;q11.2), BCR-ABL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cytogenetic finding with B-ALL with a very favorable prognosis

A

t(12;21)(p13;q22), ETV6-RUNX1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Findings to diagnose AML (2)

A

Myeloblasts >20% of nucleated cells in marrow or peripheral blood, cytogenetic findings

19
Q

Fused azurophilic granules that form small stick-like structures in the cytoplasm

20
Q

Genes associated with AML cases seen in younger patients with relatively good prognosis?

21
Q

How is ALL prognosis affected by age?

A

Worst in infants, older children, or adults

22
Q

How is ALL prognosis affected by chromosome ploidy?

A

Hyperdiploidy is associated with better prognosis

23
Q

How is ALL prognosis affected by response to therapy?

A

Slow response is worse prognosis

24
Q

How is ALL prognosis affected by T vs. B ALL?

A

B-ALL has better prognosis

25
How is ALL prognosis affected by WBC count?
Worse for higher count
26
Molecular markers currently used to predict prognosis in patients with AML with normal karyotype (3)
FLT3 ITD, NPM1, CEBPA
27
Negative prognostic factor associated with normal karyotype AML
FLT3 ITD
28
Potential complication of t(15;17)(q22;q22)
DIC
29
Prognosis of t-AML
Very poor
30
T-ALL has a _____ prognosis than B-ALL.
worse
31
T-ALL is more commonly seen in _____ (demographic).
adolescents and young adults
32
t-AML with complex karyotype, frequently whole or partial loss of chromosomes 5 or 7
Secondary to alkylating agents or radiation
33
t-AML with latency 1-2 years
Secondary to Topoisomerase II inhibitors
34
t-AML with latency 2-8 years
Secondary to alkylating agents or radiation
35
t-AML with rearrangement of MLL gene
Secondary to Topoisomerase II inhibitors
36
Therapy-related AML with an MDS stage
Secondary to alkylating agents or radiation
37
Treatment for t(15;17)(q22;q22)
All-Trans Retinoic Acid (ATRA) with arsenic salts
38
Type of acute leukemia and prognosis? t(15;17)(q22;q22)
Acute Promyelocytic Leukemia; best remission rates for AML
39
Type of ALL and prognosis? 11q23/MLL
B-ALL, poor
40
Type of ALL and prognosis? t(12;21)(p13;q22), ETV6-RUNX1
B-ALL, very good
41
Type of ALL and prognosis? T(9;22)(q34;q11.2), BCR-ABL
B-ALL, worst of all ALL
42
Types of therapy-related AML
Secondary to alkylating agents or radiation, Secondary to Topoisomerase II inhibitors
43
What feature can be used to distinguish abnormal myeloblasts?
Auer Rods
44
Which acute leukemia shows predomination of promyelocytes?
Acute Promyelocytic Leukemia; best remission rates for AML